Valiant Organics Exits DVLLP for Valiant Laboratories Shares

• Board approved cessation from subsidiary DVLLP and disposal of partnership interest, subject to shareholder approval.
• Transaction involves receiving 1.86 crore Valiant Laboratories shares as settlement for DVLLP interest.
• DVLLP contributed 11.34% to consolidated net worth but only 0.05% to turnover in Fiscal 2026.
• Transaction classified as material related party deal, valued at arm's length by independent valuation.